跳至主要内容
临床试验/IRCT20081208001497N8
IRCT20081208001497N8招募中3 期

Evaluation of the effect of melatonin on biomarkers of mitochondrial damage in patients with brain injury hospitalized in Alzahra hospital, Isfahan: A randomized placebo-controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Adult patients (age more than 18) who had traumatic brain injury included skull fracture, subdural hemorrhage, subarachnoid hemorrhage, brain contusion and laceration, intracerebral hemorrhage, intraventricular hemorrhage and traumatic axonal injury
  • Non-traumatic brain injury included strokes, infections, hypoxia and brain tumors
  • Admission within 72 hours after brain injury in intensive care unit or other wards such as neurology or neurosurgery
  • Healthy gastrointestinal tract (capable of oral ingestion or gavage of drug)

排除标准

  • Length of hospitalization less than 5 days in intensive care units or other wards
  • Hypersensitivity to melatonin
  • Hepatic failure (class C according to Child-pugh)
  • Renal failure (need dialysis)
  • Severe heart failure (Class 3 and 4 according to Newyork heart association)
  • Sepsis within first 5 days of admission

研究者

相似试验

Effect of Melatonin in brain injury | 临床试验